Network News

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Paris, October 17, 2025. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Wayrilz (rilzabrutinib) as a new treatment for immune thrombocytopenia (ITP) in adult patients who are refractory to other […]

A method developed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB enables bacterial, viral, fungal, or parasitic pathogens in sepsis patients to be identified much faster than before and with the highest precision. The approach is based on high-throughput sequencing of cell-free DNA circulating in the blood and was honored with the EARTO […]

Cambridge, UK, 08 October 2025: SPT Labtech, a pioneer in the design and development of laboratory automation and liquid handling solutions, and Agilent Technologies Inc. (“Agilent”), a global leader in analytical and clinical laboratory technologies, today announced the introduction of automated target enrichment protocols on SPT Labtech’s firefly®+ platform. Automating genomic workflows, the optimized Target […]

Herzlichen Glückwunsch an JunProf. Dr. Philipp Uhl von der Universität Heidelberg und sein Team. Für PHOENIX ist das eine ganz besondere Auszeichnung, denn als approbierter Apotheker mit Schwerpunkt in der pharmazeutischen Forschung verbindet Philipp Uhl Praxis und Forschung – genau das, was die pharmazeutische Versorgung von morgen braucht. Die Forschung des Teams könnte die Arzneimitteltherapie verändern: […]

Start-up nanoAR receives funding from a federal “exist”-Forschungstransfer grant for its anti-reflective surface technology Most people have been irritated by the reflection of sunlight on their smartphone display or their spectacles. Many solutions are available — but until now none for curved surfaces or situations with a wide range of light incidence angles. Scientists at […]

Marathon Beteiligungs AG is the lead investor, CARMA Funds also participates in €3.67 million round Heidelberg-based WMT AG today announced the completion of an equity financing round totaling €3.63 million. The lead investor, which was able to significantly expand its investment with the InnoGrowth BW program of L-Bank, is Dresden-based Marathon Beteiligungs AG, which is […]

Heidelberg, Germany, October 14th, 2025. BioMed X, today announced the launch of XFem Labs, a new Women’s Health R&D Accelerator in Heidelberg. The purpose of this initiative, which is supported by the Gates Foundation, is to establish a world-class women’s health innovation hub that advances early-stage research into scalable solutions for women in need around the world, including […]

With a closer look at genomic variation, scientists now have a faster, more precise way to uncover new links to disease Summary Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain diseases ‘ran in families’. However, through the years, scientists have kept getting better at finding ways to […]

Tumors are not a comfortable place to live: oxygen deficiency, nutrient scarcity, and the accumulation of sometimes harmful metabolic products constantly stress cancer cells. A research team from the German Cancer Research Center (DKFZ) and the Institute of Molecular Pathology (IMP) in Vienna has now discovered that the acidic pH value in tumor tissue—known as […]